Sanuwave Health Inc (SNWV) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sanuwave Health Inc   (NASDAQ: SNWV)


Sanuwave Health Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sanuwave Health Inc's ROI in the third quarter of 2026?
Sanuwave Health Inc achieved a return on average invested assets (ROI) of 18.32 % in its third quarter of 2026, this is above SNWV's average return on investment of -108.5%.
Sanuwave Health Inc invested over the 12 months ending in its third quarter of 2026 $18 million

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 7 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 18 to 19.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM -85.98 % - - - -
Investment (TTM) in Millions 16 11 19 25 11
Return On Investment (TTM) 18.32 % 86.76 % 157.73 % -4655.18 % -224.01 %
SNWV's Overall Ranking # 19 # 18 # 20 # 0 #
Seq. Investment Change TTM 7.2 % 75.01 % - - -
Seq. Net Income Change TTM -77.37 % -3.74 % 39.7 % -53.92 % -
Net Income (TTM) in Millions 3 14 15 11 23

SNWV Company Profile >> Back to SNWV Roi Comparisons >> See Annual SNWV Return On Investment



Return On Investment SNWV's Ranking
Within: No.
Industry # 3
Sector # 8
Overall # 19

Return On Investment Statistics
High Average Low
1301.96 %
-108.5 %
-952.98 %
(Dec 31 2025)   (Jun 30 2015)







Financial Statements
Sanuwave Health Inc's III. Quarter Investments $ 16 Millions SNWV's Balance sheet
Sanuwave Health Inc's III. Quarter Income $ -1 Millions Quarterly SNWV's Income Statement
SNWV's Income by Division See SNWV's Income by Division


SNWV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 19 -12 -42 -40 -38
Y / Y Investment Growth - - - - -
Net Income in Millions 24 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 121.62 % - - - -


Annual Roi Comment
In the fiscal year 2025 ROI improved to 121.62 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SNWV's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SNWV's Competitors
Subscribers only: Roi for Sanuwave Health Inc's Suppliers
Subscribers only: Return On Investment for SNWV's Customers

Other Ratios
SNWV's Roa SNWV's Inventory Turnover Ratio SNWV's Growth Rates SNWV's Dividend Statistics
SNWV's Profitability Ratios SNWV's Asset Turnover Ratio SNWV's Dividend Growth
SNWV's Roe SNWV's Valuation Ratios SNWV's Financial Strength Ratios SNWV's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %

Date modified: 2026-11-11T14:01:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.